期刊文献+

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer 被引量:12

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
下载PDF
导出
摘要 AIM To assess the validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal Cancer 29(EORTC QLQ-CR29) in Chinese patients with colorectal cancer(CRC). METHODS From March 2014 to January 2015, 356 patients with CRC from four different hospitals in China were enrolled in the study, and all patients self-administered the EORTC QLQ-CR29 and the quality of life core questionnaire(EORTC QLQ-C30). Evaluation of the scores was based on the Karnofsky Performance Scale(KPS). The reliability and validity of the questionnaires were assessed by Cronbach's α coefficient, the Spearman correlation test and Wilcoxon rank sum test.RESULTS The EORTC QLQ-CR29 showed satisfactory reliability(α > 0.7), although the urinary frequency and blood and mucus in stool dimensions had only moderate reliability(α = 0.608). The multitrait scaling analyses showed good convergent(r > 0.4) and discriminant validity. Significant differences were obtained for each item in the different KPS subgroups(KPS ≤ 80; KPS > 80). body image and most single-item dimensions showed statistically significant differences in patients with a stoma compared with the rest of the patients. CONCLUSION The EORTC QLQ-CR29 exhibits high validity and reliability in Chinese patients with CRC, and can therefore be recommended as a valuable tool for the assessment of quality of life in these patients. AIM To assess the validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal Cancer 29 (EORTC QLQ-CR29) in Chinese patients with colorectal cancer (CRC). METHODS From March 2014 to January 2015, 356 patients with CRC from four different hospitals in China were enrolled in the study, and all patients self-administered the EORTC QLQ-CR29 and the quality of life core questionnaire (EORTC QLQ-C30). Evaluation of the scores was based on the Karnofsky Performance Scale (KPS). The reliability and validity of the questionnaires were assessed by Cronbach's proportional to coefficient, the Spearman correlation test and Wilcoxon rank sum test. RESULTS The EORTC QLQ-CR29 showed satisfactory reliability (proportional to > 0.7), although the urinary frequency and blood and mucus in stool dimensions had only moderate reliability (proportional to = 0.608). The multitrait scaling analyses showed good convergent (r > 0.4) and discriminant validity. Significant differences were obtained for each item in the different KPS subgroups (KPS <= 80; KPS > 80). Body image and most single- item dimensions showed statistically significant differences in patients with a stoma compared with the rest of the patients. CONCLUSION The EORTC QLQ-CR29 exhibits high validity and reliability in Chinese patients with CRC, and can therefore be recommended as a valuable tool for the assessment of quality of life in these patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2017年第10期1891-1898,共8页 世界胃肠病学杂志(英文版)
基金 Supported by Science&Technology Innovation Commission of Shenzhen(to Lin JB) No.201404113000346 and No.JCYJ20140411150916744 the Science &Technology Project of Shenzhen Longgang District,No.201406063001007 and No.YLWS20140606101914846 the Science &Technology Project of Shenzhen Longgang District,No.20160607153104624(to Zhang YF)
关键词 Colorectal 癌症 生活的健康相关的质量 EORTC QLQ-CR29 大陆中国 Colorectal cancer Health-related quality of life EORTC QLQ-CR29 China's Mainland
  • 相关文献

参考文献2

二级参考文献14

  • 1Ministry of Health. National death survey report,2004-2005[M].Beijing:Peking Union Medical College Publication House,2008.
  • 2Lu FZ,Zhang SW,Chen YH. Investigation analysis of cancer registration in China[J].Zhong Guo Zhong Liu,2004.134-41.
  • 3Chen WQ,Zhao P,Rao KQ. A primary cancer registration system in China,2010[J].Zhonghua Yufang Yixue Zazhi,2010.374-5.
  • 4National Office for Cancer Prevention and Control.China cancer annual report,2010[M]北京:军事医学科学出版社,2011.
  • 5Curado MP,Edwards B,Shin HR. Cancer Incidence in Five Continents,Vol.Ⅸ[A].Lyon:iarc Press,2007.
  • 6Parkin DM,Chen VW,Ferlay J. Comparability and quality control in cancer registration.[=IARC Technical Report No.19,][R].Lyon:iarc Press,1994.
  • 7Felay J,Burkhard C,Whelan S. Check and conversion programs for cancer registries.[IARC Technical Report No.42.][R].Lyon:iarc Press,2005.
  • 8Chen WQ,Zhang SW,Zou XN. Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011.3-9.
  • 9Chen WQ,Zheng RS,Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China[J].Thoracic Cancer,2011.149-55.
  • 10Shopland DR,Eyre H J,Pechacek TF. Smoking-attributable cancer mortality in,1991:is lung cancer now the leading cause of death among smokers in the United States[J].Journal of the National Cancer Institute,1991.1142-8.

共引文献371

同被引文献101

引证文献12

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部